Treatment of myelodysplastic syndromes (MDS)
Tohyama, K.
Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 2): 367-372
2012
ISSN/ISBN: 0047-1852 PMID: 23133984 Document Number: 661300
Document emailed within 1 workday
Related Documents
Aviles, A.; García, L.D.; Romero, N.; Tripp, F.; González-Llaven, J. 1988: Treatment of myelodysplastic syndromes with danazol Archivos de Investigacion Medica 19(1): 73-77Hellström-Lindberg, E. 1999: Treatment of adult myelodysplastic syndromes International Journal of Hematology 70(3): 141-154
Neuwirtová, R.; Steruská, M.; Lukásová, M.; Háber, J.; Cieslar, P.; Kvasnicka, J. 1987: Personal experience in the treatment of the myelodysplastic syndromes Vnitrni Lekarstvi 33(5): 453-462
Cheson, B.D.; Zwiebel, J.A.; Dancey, J.; Murgo, A. 2000: Novel therapeutic agents for the treatment of myelodysplastic syndromes Seminars in Oncology 27(5): 560-577
Uzuka, Y.; Saito, Y. 1989: Bestatin treatment of patients with myelodysplastic syndromes Gan to Kagaku Ryoho. Cancer and ChemoTherapy 16(3 Part 1): 365-370
Bernasconi, C. 2001: Evidence-based approach to treatment of myelodysplastic syndromes Haematologica 86(9): 897-899
Kizaki, M.; Koeffler, H.P. 1992: Differentiation-inducing agents in the treatment of myelodysplastic syndromes Seminars in Oncology 19(1): 95-105
Rose, C.; Wattel, E.; Bastion, Y.; Berger, E.; Bauters, F.; Coiffier, B.; Fenaux, P. 1994: Treatment with very low-dose GM-CSF in myelodysplastic syndromes with neutropenia. A report on 28 cases Leukemia 8(9): 1458-1462
Silverman, L.R.; Holland, J.F.; Weinberg, R.S.; Alter, B.P.; Davis, R.B.; Ellison, R.R.; Demakos, E.P.; Cornell, C.J.; Carey, R.W.; Schiffer, C. 1993: Effects of treatment with 5-azacytidine on the in vivo and in vitro hematopoiesis in patients with myelodysplastic syndromes Leukemia 7(Suppl 1): 21-29
Ganser, A.; Ottmann, O.G.; Seipelt, G.; Lindemann, A.; Hess, U.; Geissler, G.; Maurer, A.; Frisch, J.; Schulz, G.; Mertelsmann, R. 1993: Effect of long-term treatment with recombinant human interleukin-3 in patients with myelodysplastic syndromes Leukemia 7(5): 696-701
García Marco, J.; Miguel Sosa, A.; García Conde, J.; Miguel García, A.; Arbona, C.; Escrig, V.; Benet, I.; Navarro, I.; Ruiz, A.; Carbonell, F. 1994: Effect of treatment with 13-cis-retinoic acid and ara-C on the hematopoietic stem cells of patients with myelodysplastic syndromes Sangre 39(4): 241-244
Gałeza-Obrepalska, B.; Dwilewicz-Trojaczek, J.; Paszkowska, M.; Kuratowska, Z. 1996: Preliminary results of erythropoietin treatment of anemia in myelodysplastic syndromes and chronic lymphocytic leukemia Polski Tygodnik Lekarski 51(19-22): 285-288
Gerhartz, H.H.; Visani, G.; Delmer, A.; Zwierzina, H.; Ribeiro, M.; Jacobs, A.; Marcus, R.; Baumelou, M.; Fière, D.; Labar, B. 1989: Low-dose Ara-C plus granulocyte/macrophage colony-stimulating factor for the treatment of myelodysplastic syndromes. EORTC Leukemia Group Bone Marrow Transplantation 4(Suppl 3): 36-37
Tassin, F.; Hermanne, J.P.; Schaaf-Lafontaine, N.; Herens, C.; Thiry, A.; Paulus, J.M.; Boniver, J.; Fillet, G. 1998: Myelodysplastic syndromes: preleukemic syndromes Revue Medicale de Liege 53(6): 357-362
Lishner, M.; Ravid, M. 1988: Myelodysplastic syndromes Harefuah 115(3-4): 73-76
Dusek, J.; Bednár, B.; Dorazilová, V.; Fakan, F.; Kerekes, Z. 1990: Myelodysplastic syndromes Ceskoslovenska Patologie 26(3): 129-134
Guisasola Zulueta, M.C.; Gilsanz Fernández, C.; Tintó del Val, J.A.; García de la Fuente, A. 1986: Myelodysplastic syndromes Revista Clinica Espanola 179(4): 190-195
Strebel, U. 1988: Myelodysplastic syndromes Therapeutische Umschau. Revue Therapeutique 45(2): 100-105
Sizoo, W.; Hagenbeek, A.; Löwenberg, B.; van 't Veer, M.B.; Sintnicolaas, K. 1987: Myelodysplastic syndromes Nederlands Tijdschrift Voor Geneeskunde 131(38): 1658-1661
Solary, E.; Fontenay, M.ël. 2010: Myeloproliferative/myelodysplastic syndromes La Revue du Praticien 60(10): 1413-1415